{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:05:37Z","timestamp":1791313537211,"version":"4.3.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["heartlungcirc.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.hlc.2018.03.007","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T19:52:44Z","timestamp":1521661964000},"page":"615-622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Homocysteine and Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities Study and the Multi-Ethnic Study of Atherosclerosis"],"prefix":"10.1016","volume":"28","author":[{"given":"Yasuhiko","family":"Kubota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R.","family":"Heckbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faye L.","family":"Norby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Folsom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2018.03.007_bib0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ajcn\/72.2.315","article-title":"Homocysteine and cardiovascular disease: cause or effect","volume":"72","author":"Brattstr\u00f6m","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.hlc.2018.03.007_bib0010","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: an independent risk factor for vascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2018.03.007_bib0015","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2018.03.007_bib0020","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","author":"Homocysteine Studies Collaboration","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2018.03.007_bib0025","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.289.10.1251","article-title":"Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction","volume":"289","author":"Vasan","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2018.03.007_bib0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2018.03.007_bib0035","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2018.03.007_bib0040","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"B\u00f8naa","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2018.03.007_bib0045","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2018.03.007_bib0050","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","article-title":"Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial","volume":"299","author":"Albert","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2018.03.007_bib0055","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(07)60854-X","article-title":"Efficacy of folic acid supplementation in stroke prevention: a meta-analysis","volume":"369","author":"Wang","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2018.03.007_bib0060","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1212\/WNL.0b013e3182a823cc","article-title":"Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: a meta-analysis","volume":"81","author":"Ji","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.hlc.2018.03.007_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001177","article-title":"Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias","volume":"9","author":"Clarke","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.hlc.2018.03.007_bib0070","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003347","article-title":"Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms","volume":"5","author":"Violi","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hlc.2018.03.007_bib0075","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIRCULATIONAHA.111.039677","article-title":"Atrial fibrillation: current knowledge and future directions in epidemiology and genomics","volume":"124","author":"Magnani","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.03.007_bib0080","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ahj.2004.03.017","article-title":"Hyperhomocysteinemia and vitamin B6 deficiency: new risk markers for nonvalvular atrial fibrillation","volume":"148","author":"Marcucci","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.hlc.2018.03.007_bib0085","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/europace\/eun140","article-title":"Circulating homocysteine levels in patients with radiofrequency catheter ablation for atrial fibrillation","volume":"10","author":"Shimano","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.hlc.2018.03.007_bib0090","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.109.882241","article-title":"Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community","volume":"121","author":"Schnabel","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.03.007_bib0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1536\/ihj.51.30","article-title":"High homocysteine levels predict the recurrence of atrial fibrillation after successful electrical cardioversion","volume":"51","author":"Naji","year":"2010","journal-title":"Int Heart J"},{"key":"10.1016\/j.hlc.2018.03.007_bib0100","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jtcvs.2012.07.099","article-title":"Increased plasma homocysteine predicts arrhythmia recurrence after minimally invasive epicardial ablation for nonvalvular atrial fibrillation","volume":"146","author":"Nasso","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hlc.2018.03.007_bib0105","first-page":"66","article-title":"Plasma homocysteine levels predict early recurrence after catheter ablation of persistent atrial fibrillation","volume":"19","author":"Yao","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hlc.2018.03.007_bib0110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives","volume":"129","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.hlc.2018.03.007_bib0115","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.CIR.98.3.204","article-title":"Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study","volume":"98","author":"Folsom","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.03.007_bib0120","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/aje\/kwf113","article-title":"Multi-Ethnic Study of Atherosclerosis: objectives and design","volume":"156","author":"Bild","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.hlc.2018.03.007_bib0125","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0003-2697(88)90332-6","article-title":"Measurement of total plasma cysteamine using high-performance liquid chromatography with electrochemical detection","volume":"168","author":"Smolin","year":"1988","journal-title":"Anal Biochem"},{"key":"10.1016\/j.hlc.2018.03.007_bib0130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0021-9150(03)00161-8","article-title":"B vitamin status and inflammatory markers","volume":"169","author":"Folsom","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.hlc.2018.03.007_bib0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.hlc.2018.03.007_bib0140","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/jth.12223","article-title":"Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis","volume":"11","author":"Adams","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.hlc.2018.03.007_bib0145","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jamainternmed.2017.1877","article-title":"Association of educational attainment with lifetime risk of cardiovascular disease: the Atherosclerosis Risk in Communities Study","volume":"177","author":"Kubota","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.hlc.2018.03.007_bib0150","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/01.CIR.75.3.565","article-title":"Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings","volume":"75","author":"Casale","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.03.007_bib0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ahj.2009.05.010","article-title":"Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study","volume":"158","author":"Alonso","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.hlc.2018.03.007_bib0160","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001082","article-title":"Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities study","volume":"3","author":"Alonso","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hlc.2018.03.007_bib0165","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/STROKEAHA.108.534735","article-title":"Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study","volume":"40","author":"Soliman","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.hlc.2018.03.007_bib0170","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002907","article-title":"Carotid intima-media thickness and arterial stiffness and the risk of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) Study, Multi-Ethnic Study of Atherosclerosis (MESA), and the Rotterdam Study","volume":"5","author":"Chen","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hlc.2018.03.007_bib0175","series-title":"Systematic reviews in health care: meta-analysis in context","author":"Egger","year":"2001"},{"key":"10.1016\/j.hlc.2018.03.007_bib0180","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCEP.107.754564","article-title":"Atrial remodeling and atrial fibrillation: mechanisms and implications","volume":"1","author":"Nattel","year":"2008","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hlc.2018.03.007_bib0185","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jacc.2015.06.1313","article-title":"Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications","volume":"66","author":"Dzeshka","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2018.03.007_bib0190","doi-asserted-by":"crossref","first-page":"H2825","DOI":"10.1152\/ajpheart.00377.2006","article-title":"Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC","volume":"291","author":"Moshal","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.hlc.2018.03.007_bib0195","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1152\/physrev.1999.79.1.215","article-title":"Molecular mechanisms of myocardial remodeling","volume":"79","author":"Swynghedauw","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.hlc.2018.03.007_bib0200","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/jcp.20752","article-title":"Homocysteine-induced myofibroblast differentiation in mouse aortic endothelial cells","volume":"209","author":"Sen","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.hlc.2018.03.007_bib0205","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1440-1681.2007.04671.x","article-title":"Homocysteine inhibits potassium channels in human atrial myocytes","volume":"34","author":"Cai","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.hlc.2018.03.007_bib0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(95)92113-3","article-title":"Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations","volume":"346","author":"Naurath","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2018.03.007_bib0215","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1161\/01.CIR.103.23.2788","article-title":"Low circulating vitamin B(6) is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels","volume":"103","author":"Friso","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.03.007_bib0220","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.jacc.2007.06.054","article-title":"Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data","volume":"50","author":"Issac","year":"2007","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950618301227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950618301227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T12:36:29Z","timestamp":1552307789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950618301227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1443950618301227"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2018.03.007","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homocysteine and Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities Study and the Multi-Ethnic Study of Atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2018.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}